TL;DREmployers with virtual GI care benefits reduce GI-related medical spend by up to 30%, saving an average of $2,800 per enrolled employee annually (American Gastroenterological Association, 2024).

What is the ROI of virtual GI care for employers?

Virtual GI care delivers an average of $2,800 in annual savings per enrolled employee by reducing unnecessary specialist visits, ER utilization and surgical procedures (American Gastroenterological Association, 2024). For a self-insured employer with 5,000 lives, that represents more than $14 million in addressable medical spend, most of which is currently going unmanaged.

What this means for employersA mid-size employer running unmanaged GI spend is likely absorbing six- to seven-figure costs that a structured virtual care program could cut by nearly a third in year two.

Why do digestive conditions cost employers $3,200 per IBS patient each year?

Digestive conditions including IBS, Crohn's disease, IBD and GERD now represent the third-largest category of employer medical spend, behind only musculoskeletal and mental health conditions (BCBS Health Index, 2024). BCBS data shows GI-related claims increased 22% between 2020 and 2024, driven by delayed diagnoses, overuse of high-cost imaging and rising specialty drug costs. What makes GI spend particularly difficult to control is that most of it is driven by employees who never receive a clear diagnosis, cycling through primary care visits, urgent care and the ER without resolution.

What this means for employersCrohn's disease alone costs nearly $18,500 per affected employee per year. For a workforce of 5,000 with average GI prevalence, that category alone represents millions in controllable spend.

How does virtual-first GI care reduce employer costs by up to 30%?

The mechanism is earlier, more consistent intervention. Traditional GI care is episodic: an employee waits six to eight weeks to see a gastroenterologist, receives a one-time recommendation and may not follow up for months. Virtual-first care replaces that model with continuous management: regular check-ins, proactive medication adjustments and coordinated specialist referrals only when truly necessary.

• Eliminates unnecessary specialist referrals: average wait time drops from six to eight weeks to a same-week virtual consult (AHRQ, 2023)
• Reduces GI-related ER visits by 31% through proactive care management (American Gastroenterological Association, 2024)
• Lowers surgical authorization rates for conditions manageable with diet and medication
• Improves medication adherence for IBD and Crohn's patients, reducing flare-related hospitalizations (Crohn's and Colitis Foundation, 2024)
• Reduces absenteeism: employees with managed GI conditions miss an average of four fewer workdays per year (Bureau of Labor Statistics, 2023)

What this means for employersThe biggest driver of savings is upstream: catching and managing flares before they become ER visits or surgical cases. Virtual care makes that intervention continuous rather than episodic.

What does the ROI timeline look like for a self-insured employer?

Most employers see measurable claims reduction within six to nine months of launch as enrolled employees stabilize their conditions and reduce high-cost utilization. Full program ROI is typically realized in year two, when the compounding effect of reduced flares, fewer specialist referrals and lower specialty drug costs becomes visible in claims data (HFMA, 2023). Programs with active employee communication campaigns reach 25-30% member utilization by year three, significantly expanding the savings base (Kaiser Family Foundation, 2024).

What this means for employersYear one savings are real but conservative. The employer case for virtual GI care compounds over time as more employees enroll and conditions that previously drove recurring spend become consistently managed.

Frequently asked questions